MedPath

RAPAMUNE 0,5 mg COMPRIMIDOS RECUBIERTOS

RAPAMUNE 0,5 mg COMPRIMIDOS RECUBIERTOS

Commercialized
Register Number

01171013

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Sep 15, 2010

Dosage Form

COMPRIMIDO RECUBIERTO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number01171013
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

SIROLIMUSActive
Quantity: 0,5 mg
Name: SIROLIMUS

ATC CLASSIFICATION (3)

L04A
L04AH
L04AH01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.